Advertisement

A lot in flux at FDA, CDER’s Jacqueline Corrigan-Curay tells employees


Thank you for reading this post, don't forget to subscribe!

WASHINGTON — Outgoing Meals and Drug Administration regulator Jacqueline Corrigan-Curay acknowledged to employees that a lot remains to be in flux on the company, weeks earlier than she retires.

“We’re leaner and subsequently we have now to search out methods to be environment friendly and do issues in new methods,” she advised employees, in accordance with a recording of a city corridor assembly obtained by STAT. 

She didn’t say who would be the subsequent chief of the Middle for Drug Analysis and Analysis as soon as she retires subsequent month. Her retirement is the newest in a sequence of exits of senior officers on the FDA, who’ve both chosen to take early retirements, left for different jobs, or been compelled out by political appointees.

STAT+ Unique Story

STAT+





This text is unique to STAT+ subscribers

Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.

Have already got an account? Log in

View All Plans

To learn the remainder of this story subscribe to STAT+.

Subscribe